Mike Dyson, Ph.D., is Chief Technology Officer and co-founder at IONTAS Ltd., a therapeutic antibody discovery company. He is a co-inventor of the IONTAS mammalian cell antibody display platform and has acted as the project leader for several successful therapeutic antibody discovery projects in immuno-oncology and inflammatory disease areas approaching IND filing. Mike was previously Head of Protein Engineering at Acambis plc (acquired by Sanofi) and Project Leader at the Wellcome Trust Sanger Institute. He holds a PhD in organic synthetic chemistry from the University of Birmingham and post-docs at MIT and the Universities of Edinburgh and Cambridge. He has published 31 papers and book chapters (cited over 1300 times, h-index 19) and is inventor on 10 US patent and patent applications.